Tiziana Life Sciences (TLSA) Current Leases (2019 - 2025)

Tiziana Life Sciences (TLSA) has reported Current Leases for 7 consecutive years, with $222000.0 the latest figure, recorded in Q4 2025.

• Quarterly Current Leases rose 109.43% year-over-year to $222000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $222000.0 (up 109.43% YoY) and the FY2025 annual result came in at $222000.0, up 109.43% from the prior year.
• Current Leases advanced to $222000.0 in Q4 2025 per TLSA's latest filing, from $107000.0 in the prior quarter.
• Over the last five years, Current Leases for TLSA reached as high as $232000.0 in Q2 2021 and fell as low as $106000.0 in Q4 2024.
• A 5-year average of $156500.0 and a median of $140000.0 in 2023 frame the typical range for Current Leases.
• The largest YoY upside for Current Leases was 109.43% in 2025 against a maximum downside of 24.65% in 2025.
• Year by year, Current Leases stood at $232000.0 in 2021, then sank by 47.41% to $122000.0 in 2022, then grew by 13.11% to $138000.0 in 2023, then declined by 23.19% to $106000.0 in 2024, then jumped by 109.43% to $222000.0 in 2025.
• According to Business Quant data, Current Leases over the past three periods registered $222000.0, $107000.0, and $106000.0 for Q4 2025, Q2 2025, and Q4 2024 respectively.